CSC
BIO icon

Caldwell Sutter Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Caldwell Sutter Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67K Hold
6
– – ﹤0.01% 771
2025
Q4 		$1.82K Hold
6
– – ﹤0.01% 755
2025
Q3 		$1.68K Hold
6
– – ﹤0.01% 756
2025
Q2 		$1.45K Hold
6
– – ﹤0.01% 752
2025
Q1 		$1.46K Hold
6
– – ﹤0.01% 766
2024
Q4 		$1.97K Hold
6
– – ﹤0.01% 747
2024
Q3 		$2.01K Hold
6
– – ﹤0.01% 758
2024
Q2 		$1.64K Hold
6
– – ﹤0.01% 778
2024
Q1 		$2.08K Hold
6
– – ﹤0.01% 754
2023
Q4 		$1.94K Hold
6
– – ﹤0.01% 766
2023
Q3 		$2.15K Hold
6
– – ﹤0.01% 722
2023
Q2 		$2.27K Buy
+6
New +$2.44K ﹤0.01% 726

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return